Cardiovascular disease and related metabolic disorders such as diabetes, obesity and fatty liver disease are major causes of morbidity and mortality worldwide. They have many common features, such as dyslipidemia and inflammation.
By exploring these processes through translational research, connecting basic science and the clinic, we wish to build a foundation for the development of new diagnostic and treatment targets for cardiometabolic disease.
Our research group works in the cross-section between molecular biology and biochemistry, and cardiovascular, cerebrovascular and endocrine medicine. Our ambitious goal is to delineate novel therapeutic targets and biomarkers.
Tuva Børresdatter Dahl is acting group leader while Bente Halvorsen is on a sabbatical in the USA during 2022/23.
The group uses different research approaches, ranging from analyses of blood and tissue samples from patients, to studies in genetically modified mice and cell culture systems, using advanced cellular and molecular biology. The group consists of people with different educational background and includes medical doctors, nutritionists, biochemists and engineers. Such multidisciplinary competence is a great strength of our research group.
The research group is a part of the Research Institute of Internal Medicine at Rikshospitalet.
Long term objectives
- To implement imaging in clinical, preclinical models and cell systems
- Intervention study